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7 CURRENTOPINION Exercise-associated glucose metabolism in
individuals with type 1 diabetes mellitus Copyright 
www.co-clinicalnutrition.comLia Bally, Markus Laimer, and Christoph StettlerPurpose of review
The primary focus of this review is threefold: first, to summarize available knowledge on exercise-
associated glucose metabolism in individuals with type 1 diabetes mellitus (T1DM); second, to elucidate
physiological mechanisms predisposing to glycemic variations in patients in T1DM; and third, to describe
novel approaches derived from physiological perceptions applicable to stabilize exercise-related glycemia
in individuals with T1DM.
Recent findings
Recent studies corroborate the concept that despite partial differences in counter-regulatory mechanisms
individuals with T1DM do not fundamentally differ in their glucose response to exercise when compared
with healthy individuals if studies are performed under standardized conditions with insulin and glucose
levels held close to physiological ranges. Novel approaches derived from a better understanding of
exercise-associated glucose metabolism (e.g., the concept of intermittent high-intensity exercise) may
provide alternative ways to master the challenges imposed by exercise to individuals with T1DM.
Summary
Exercise still imposes high demands on patients with T1DM and increases risks for hypoglycemia and
hyperglycemia. Deeper insight into the associated metabolic pathways has revealed novel options to
stabilize exercise-associated glucose levels in these patients.
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Although the beneficial effects of physical activity
are well documented in individuals with type 2
diabetes [1], the role of exercise is ambiguous in
patients with type 1 diabetes mellitus (T1DM) with
studies even revealing worsening of glycemic con-
trol associated with frequent exercise [2,3]. In
healthy individuals, exercise-associated glucose
homeostasis is maintained by a complex endocrine
interplay with insulin as the glucose-lowering hor-
mone on one side and its counterparts [mainly,
glucagon, catecholamines, cortisol, and growth
hormones (GH)] on the other side. This balance
is compromised in patients with T1DM in whom
regulation of endogenous insulin (and at least partly
also of glucagon) is impaired. Although modern
insulin therapy reveals many options to adapt insu-
lin doses and levels to the requirements by physical
exercise, current approaches are still far from per-
fect. The purpose of this review is to summarize
available knowledge regarding exercise-associated
glucose metabolism in individuals with T1DM,© 2015 Wolters Kluwer elucidate physiological mechanisms predisposing
to glycemic fluctuations in these patients, and
describe novel approaches derived from physiologi-
cal perceptions that may be applied to stabilize
exercise-related glycemia in individuals with T1DM.GENERAL ASPECTS OF EXERCISE-
ASSOCIATED GLUCOSE METABOLISM
During exercise, the skeletal muscle initially uses
local glucose and, in a second step, converts muscle
glycogen to glucose as an energy substrate. In
addition to these intramyocellular stores, glycogenHealth, Inc. All rights reserved.
Volume 18  Number 4  July 2015
KEY POINTS
 Although exercise is established to be beneficial in
individuals with type 2 diabetes, its role is more
ambivalent in patients with T1DM.
 The loss of endogenous regulation of insulin secretion
and the consequent need of exogenous insulin delivery
(with the related risk of unphysiological insulin levels)
predispose to an increased risk of exercise-associated
glucose fluctuations in individuals with T1DM.
 Supraphysiological insulin levels may impair hepatic
glucose output and limit the physiological shift from
glucose to fatty acid oxidation in the course of exercise
– the corresponding literature is, however,
still controversial.
 When studied under standardized conditions
approximating physiological levels of glucose and
insulin, there is little evidence of a generic difference in
exercise-associated fuel metabolism in individuals with
T1DM compared with their healthy counterparts.
 A thorough understanding of exercise-associated fuel
metabolism may lead to novel therapeutic approaches
(e.g., IHE) to improve stability of exercise-
associated glucose.
Exercise-associated glucose metabolism Bally et al.reserves are also stored in the liver, the latter differ-
ing from themuscle by its ability to convert glucose-
6-phosphate (derived from glycogen) to glucose that
can then be systemically distributed to the working
muscle in a third step. Glucose transport across the
myocellular cell membrane is the rate-limiting step
in this process. Blood glucose enters skeletal muscle
through specific glucose transporters [glucose trans-
porter isoform 4 (GLUT4)]. GLUT4 gene expression
in working muscle directly increases after a single
bout of exercise [4]. Expression of GLUT4 as well as
recruitment of GLUT4-containing vesicles is, there-
fore, a rapid process that has been shown to be
regulated through two different pathways. On the
one hand, recruitment follows stimulation by insu-
lin via insulin receptors, followed by the intracellu-
lar pathway of insulin receptor substrate 1 and PI-3-
kinase. On the other, physical exercise itself
increases transport of GLUT4 toward cell mem-
brane. The precise mechanisms of this latter path-
way are not yet entirely understood, but it is
assumed that autocrine and paracrine effects follow-
ing muscle contraction associated with a release of
intracellular calcium from the sarcoplasmatic retic-
ulum may be involved. As the two stimuli (insulin
and exercise) use different pathways, the effect of
both stimuli together is additive. As a consequence,
physiologically, insulin is downregulated during
exercise in healthy individuals, thereby reducing Copyright © 2015 Wolters Kluwe
1363-1950 Copyright  2015 Wolters Kluwer Health, Inc. All rights resethe risk of overstimulation of GLUT4 in skeletal
muscle (e.g., balancing the increased insulin sensi-
tivity) and increasing hepatic glycogenolysis (inhib-
ited by higher insulin levels). These adjustments
in the insulin secretion are essential to preserve
normoglycemia in nondiabetic individuals during
physical activity.EXERCISE-ASSOCIATED GLUCOSE
METABOLISM IN INDIVIDUALS WITH
TYPE 1 DIABETES MELLITUS
The above-mentioned hormonal adaptations are
essentially lost in patients with T1DM. As outlined
before, treatment in T1DM consists of exogenous
insulin that is applied subcutaneously (as opposed
to the physiological portal insulin secretion in
healthy individuals), resulting in an imbalance of
comparably high peripheral but relatively low por-
tal insulin levels. In addition, exogenous insulinhas
to cover insulin requirements through periods with
considerably differing requirements. Guidelines for
patients with T1DM generally recommend
reduction of insulin before, during, and also after
physical exercise and/or to ingest additional carbo-
hydrates, if necessary, to balance the increased
insulin sensitivity inducedby exercise [1].However,
these adaptations may be difficult to implement in
reality. Insulin treatment in patients with T1DM
today either consists of multiple daily injections of
rapid-acting insulin (used to cover meals and cor-
rect increased glucose levels) and long-acting basal
insulin (covering basal insulin requirements). Alter-
natively, treatment is performed by continuous
subcutaneous insulin infusion (CSII). Although,
in general, both treatments have shown to be effec-
tive in the reduction of long-term diabetic compli-
cations, they fundamentally differ in their
flexibility with regard to rapid dose adjustments:
almost instant reductions of insulin delivery are
feasible for patients using CSII. However, a con-
siderable percentage of individuals with T1DM
decide against CSII but still regularly perform
physical exercise. The most frequently used long-
acting insulin analogs today induce glucose-low-
ering effects over 12–24h, some even as long as
48h.Although this is convenient to thepatientwho
needs to inject basal insulin only once or twice
daily, it precludes a flexible dose reduction for
active patients. In addition to insulin therapy,
many other factors may impact on exercise-related
glucosemetabolism such as site of insulin injection;
duration, intensity, and timing of exercise; compo-
sition and timing of the last meal before as well as
nutrition during and after exercise; andpre-exercise
blood glucose levels [5].r Health, Inc. All rights reserved.
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CarbohydratesThe specific role of the levels of insulin and
glucose on exercise-associated fuel metabolism,
respectively, has been assessed in several recent
studies. Chokkalingam et al. [6] showed in their
study comparing differing insulin levels that hyper-
insulinemia translated into an increased exogenous
glucose utilization during exercise, however, with-
out sparing of intramyocellular glycogen. In a fur-
ther study, they investigated exercise-induced
hepatic glycogen consumption in individuals with
T1DM compared with healthy controls. Despite the
significantly higher insulin and glucose levels in
T1DM, there were no differences in substrate oxi-
dation and hepatic glycogen consumption between
the groups [7]. In a complementary setting, we
investigated the impact of differing glucose levels
at identical and comparably low insulinemia on
fuel metabolism during aerobic exercise in patients
with T1DM [5]. We found a higher rate of carbo-
hydrate oxidationduring exercise inhyperglycemia
than in euglycemia with inverse findings for lipid
oxidation. Interestingly, intramyocellular glycogen
was not spared in hyperglycemia and glycogen
breakdown was even increased in this condition
compared with euglycemia. This latter finding
may be because of the fact that in the presence of
identical insulin concentrations, hyperglycemia
rapidly increased pre-exercise intramuscular glyco-
gen, and higher pre-exercise glycogen levels have
per se been shown to induce higher exercise-associ-
ated glycogen consumption [5]. Still, these results
corroborate the concept that under euglycemic
conditions with near-physiological insulin doses,
patients with T1DM behave similarly to nondia-
betic individuals, revealing a shift from carbo-
hydrate oxidation toward a predominance of lipid
oxidation in the course of aerobic exercise in eugly-
cemia. The corresponding metabolic mechanisms
for the deviations found under hyperglycemic con-
ditions (e.g., persistence of artificially high glucose
oxidation) are currently not entirely clarified. In
addition to difference in the secretion of counter-
regulatory hormones (e.g., cortisol andGH) accord-
ing to glycemic levels [8], interleukin-6 and
acetylcarnitin have been suggested as potential
candidates [9,10,11
&
]. Taken together, current find-
ings speak strongly against generic metabolic
defects in exercise-associated fuel metabolism in
individuals with T1DM if exercise is performed
under near-physiological conditions (e.g., euglyce-
mia and comparably low insulin levels). This goes
along with very recent data showing that glycogen
storage capacity in liver and skeletal muscle of well
controlled patients with T1DM is fully comparable
to healthy individuals if studied under standardized
conditions [12]. Copyright © 2015 Wolters Kluwer 
430 www.co-clinicalnutrition.comHORMONAL RESPONSE DURING
EXERCISE AND IMPLICATIONS FOR
INDIVIDUALS WITH TYPE 1 DIABETES
MELLITUS
Depending on exercise intensity, the hormonal
response to exercise includes a broad variety of hor-
monal players, due to their potential glucose-increas-
ing effect generally labeled as antagonists to insulin
or counter-regulatory hormones. Essentially, these
encompass glucagon, catecholamines, cortisol, and
GH. In moderate-intensity exercise of limited
duration in healthy individuals, the portal gluca-
gon-to-insulin ratio is thought to be the main deter-
minant in the regulation of endogenous glucose
production and, consequently, energy supply to the
working muscle. In contrast, catecholamines (e.g.,
norepinephrine and epinephrine) become more
important during exercise of longer duration or
higher intensity [13]. In individuals with T1DM,
however, the hormonal interplay may be affected
by several disease-specific factors; on the contrary,
in addition to insulin, glucagon secretion also has
been shown to be affected in the course of T1DM
although there appears to be a difference between
reactions to hypoglycemia (impaired) and exercise
(preserved) [14]. Of note, counter-regulatory
measures encountered during intense exercise are
also involved in the physiological reaction to hypo-
glycemia,which is a relevant incident inpatientswith
T1DM. Previous studieshave shown thatpronounced
and repetitive hypoglycemia prior to exercise may
reduce subsequent secretion of counter-regulatory
hormones, thereby increasing the risk of exercise-
associated hypoglycemia and potentially giving
way toavicious circle [15]. Reciprocally, prior exercise
can impair the counter-regulatory response to sub-
sequent episodes of hypoglycemia [15]. Interestingly,
a sex-specific difference in the hormonal-regulatory
response to euglycemic exercise has recently been
reported, revealing a reduced increase in catechol-
amines and GH in female patients with T1DM [16].
In contrast, after antecedent hypoglycemia, the
same group suggested better preserved neuroendo-
crine (glucagon and catecholamines) and metabolic
homeostatic responses during exercise in women
compared with men [17]. Finally, it has been
suggested that individuals with T1DM may reveal
defects in the secretion of GH, further contributing
to a limited counter-regulation during hypoglycemia
and/or during exercise. However,more recent reports
have shown that exercise-induced GH secretion in
T1DMpatients ingoodmetabolic control and studied
under highly standardized conditions is entirely
comparable tonondiabetic individuals [8]. It is, there-
fore, not unlikely that many of the findings in earlier
studies pointing toward impaired counter-regulationHealth, Inc. All rights reserved.
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Exercise-associated glucose metabolism Bally et al.in T1DMmay be essentially due to settings including
patients in suboptimal metabolic control rather than
proving generic differences.IMPACT OF HIGH-INTENSITY EXERCISE
TO GLUCOSE METABOLISM IN TYPE 1
DIABETES MELLITUS
In healthy individuals, high-intensity exercise and
thecorresponding increase incounter-regulatoryhor-
mones may transiently lead to moderate hyperglyce-
mia that is rapidly counterbalanced by an increase in
endogenous insulin [18]. Lack of endogenous insulin
regulation precludes this automatic compensation in
patientswithT1DM,adding the riskofhyperglycemia
to the fearofhypoglycemia, therebyunderscoring the
complexity of exercise-associated glucose variations
[3]. The induction of hyperglycemia has previously
been described as an undesired side-effect of high-
intensity exercise in T1DM. Interestingly, more
recent studies now suggest that counter-regulatory
hormones may even be of potential use to stabilize
exercise-related glucose by compensating for the
increased insulin sensitivity generally associatedwith
exercise. For example, it has been shown that a single
all-out sprint of 10 s directly after exercise may coun-
terbalance the postexercise decrease of glucose
induced by activation of GLUT4 [19]. Interestingly,
the identical single intervention performed before
exercise did not prevent a drop in glucose during
exercise but still induced a stabilization of postexer-
cise glucose levels [20]. Similar glucose-stabilizing
effects have been suggested by adding resistance exer-
cise (which relies on similar fuel sources and involves
comparable amounts of counter-regulatory hor-
mones) to aerobic exercise [11
&
,21,22].NOVEL CONCEPTS BASED ON
PHYSIOLOGICAL PERCEPTIONS
Based on the glucose-stabilizing effects of single
boutsofintenseexercise,ithasrecentlybeensuggested
thatthecombinationofrepetitiveboutsofhigh-inten-
sityexercisewithexerciseof lowormoderate intensity
(commonly referred to as intermittent high-intensity
exercise or IHE)mayprovide anovelway toovercome
the problem of exercise-related hypoglycemia
[19,20,23
&&
,24,25]. Inastudyofsevenindividualswith
T1DM assessing the impact of short sprints (4 s) per-
formed every 2min over an exercise duration of
30min at low-to-moderate intensity, Guelfi et al.
[25] found a reduction in exercise-related glucose
decline and a stabilization of postexercise glucose
levels. Maran et al. [26] used sprints of comparable
duration (5 s) every 2min over 30min of exercise and
investigated eight participants with T1DM. Despite a Copyright © 2015 Wolters Kluwe
1363-1950 Copyright  2015 Wolters Kluwer Health, Inc. All rights reseslight albeit not significant increase of short-term
postexerciseglucoseinIHE,theyreportedanincreased
riskofdelayedhypoglycemiaafter theexercise,poten-
tiallyrelatedtoanincreasedconsumptionofglycogen
reserves.Conversely, a recent study in11athleteswith
T1DM assessed the impact of all-out sprints of 15 s
performedevery5minover45minofexercise (50%of
max workload) and found similar declines of glucose
during exercise but a lower risk of nocturnal postex-
ercise hypoglycemia associated with IHE [24]. The
discrepancy regarding postexercise hypoglycemia
found in these two trials may on the one hand be
due to the difference in training status of the study
population; Maran et al. [26] included comparably
untrained individuals with T1DM whereas Iscoe and
Riddell [24] investigated well trained type 1 diabetic
athletes. Theremay also be an impact of sex asMaran
et al. included male individuals, exclusively, whereas
Iscoe and Riddell allowed for the inclusion of both
sexes. In addition, both studies did not quantify pre-
trial levelsofglycogenstores inliverorskeletalmuscle.
Therefore, higher pre-exercise glycogen stores as a
potential stabilizing factor in the study of Iscoe and
Riddell may not be ruled out.
Taken together, a limited number of studies have
so far investigated the impact of IHE on glucose levels
during and after exercise in individuals with T1DM.
Results differ considerably with regard of the amount
of glucose stabilization and important discrepancies
appear regarding delayed postexercise hypoglycemia.
Such disparities may be related to differing inclusion
criteria and varying standardization procedures but
also to a variety of IHE strategies. In essence, IHE in
previous studies reflected activity patterns of typical
team sports. However, the problemof exercise-associ-
ated hypoglycemia is frequently encountered during
aerobic exercise of longer duration (e.g., running or
biking for 1 or 2h), thereby limiting the direct appli-
cability of previous study results to daily clinical prac-
tice. To the best of our knowledge, only one studyhas
so far investigated the impactof IHEduringexerciseof
longer duration [27], but in this study sprints of 10 s
were performed every 2min, again making this regi-
mendemandingtotheindividualand,thus,makingit
difficult to draw conclusions for strategies in endur-
ance exercise. It is, thus, currently unknown,whether
a regimenusing less-frequent sprints butover a longer
exercise durationmay induce stabilization of glucose
levels throughout but also after exercise. In addition,
previous studies did not focus on pretrial standardiz-
ation of glycogen stores in liver andmuscle, as well as
quantification of glycogen before and after exercise.
Thus, the issue of postexercise hypoglycemia poten-
tially associated with IHE remains unsolved. In a cur-
rent research project, our group investigates the
impact of repetitive all-out sprints of 10 s performedr Health, Inc. All rights reserved.
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Carbohydratesevery 10minduring anaerobic exercise (e.g., 45–50%
of maximum workload) over 90min. Preliminary
results show a significantly reduced amount of
exogenous glucose requested tomaintain euglycemia
in IHE compared with continuous exercise without
sprints. The difference is essentially traced back to
increased amounts of hepatic and to a lesser amount
of myocellular glycogen consumption in IHE [28].
These findings corroborate the potential of IHE to
reduce exercise-associated glucose variations. How-
ever, there is the potential downsize of an increased
consumption of glycogen stores and, consequently,
an increased riskof postexercise hypoglycemia associ-
ated with IHE.CONCLUSION
Although in healthy individuals glucose homeosta-
sis is permanently maintained by a complex meta-
bolic interplay, this delicate balance is significantly
compromised in patients with T1DM rendering glu-
cose metabolism prone to variations toward both
hyperglycemia and hypoglycemia. Although mod-
ern therapeutic approaches provide important tools
to improve the necessary adaptations, current treat-
ment is still far from perfect. A better understanding
of exercise-associated fuel metabolism will further
our attempts to improve therapeutic recommen-
dations. Novel approaches derived from physiologi-
cal perceptions may offer alternative ways to answer
to these challenges. Importantly, recent studies
speak against generic differences in exercise-associ-
ated glucose metabolism in individuals with T1DM
compared with their healthy counterparts if studies
are performed under standardized and near-physio-
logical conditions.
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